The Biologics and Biosimilars Congress: Asia 2018 is dedicated to monoclonal antibody, recombinant protein, antibody-drug conjugates (ADCs), vaccine R&D and commercialisation.
Topics
- Immunotherapy
- Antibody-based therapeutics & engineering
- Antibody-drug conjugates(ADCs)
- Protein biotherapeutics
- Vaccine R&D and commercialisation
- Monoclonal antibody (Mab) and antibody-derived therapeutics for chronic diseases
